发布求助
文献互助 智能选刊 最新文献

Drugs of The Future最新文献

筛选
英文 中文
European Society of Medical Oncology (ESMO) - 2021 Annual Congress. Virtual - September 16-21, 2021 欧洲肿瘤医学学会(ESMO) - 2021年年会。虚拟- 2021年9月16日至21日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.1.3393254
G. Croasdell
{"title":"European Society of Medical Oncology (ESMO) - 2021 Annual Congress. Virtual - September 16-21, 2021","authors":"G. Croasdell","doi":"10.1358/dof.2022.47.1.3393254","DOIUrl":"https://doi.org/10.1358/dof.2022.47.1.3393254","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navafenterol. Dual M3 receptor antagonist/beta2-adrenoceptor agonist (MABA), Treatment of chronic obstructive pulmonary disease Navafenterol。双M3受体拮抗剂/ β -肾上腺素受体激动剂(MABA)，治疗慢性阻塞性肺疾病
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.10.3461269
M. Matera, P. Rogliani, M. Cazzola
{"title":"Navafenterol. Dual M3 receptor antagonist/beta2-adrenoceptor agonist (MABA), Treatment of chronic obstructive pulmonary disease","authors":"M. Matera, P. Rogliani, M. Cazzola","doi":"10.1358/dof.2022.47.10.3461269","DOIUrl":"https://doi.org/10.1358/dof.2022.47.10.3461269","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
International Association for the Study of Lung Cancer (IASLC) - 23rd World Conference on Lung Cancer (WCLC 2022). Vienna - August 6-9, 2022 国际肺癌研究协会(IASLC) -第23届世界肺癌大会(WCLC 2022)。维也纳——2022年8月6日至9日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.10.3487259
R. Bandari
{"title":"International Association for the Study of Lung Cancer (IASLC) - 23rd World Conference on Lung Cancer (WCLC 2022). Vienna - August 6-9, 2022","authors":"R. Bandari","doi":"10.1358/dof.2022.47.10.3487259","DOIUrl":"https://doi.org/10.1358/dof.2022.47.10.3487259","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Society of Human Genetics Annual Meeting. Virtual - October 18-22, 2021 美国人类遗传学学会年会。虚拟- 2021年10月18日至22日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.2.3393247
N. Fernández
{"title":"American Society of Human Genetics Annual Meeting. Virtual - October 18-22, 2021","authors":"N. Fernández","doi":"10.1358/dof.2022.47.2.3393247","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3393247","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline on the move - March 2022 管道在移动- 2022年3月
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.3.3422310
L. Fernández Bertolín
{"title":"Pipeline on the move - March 2022","authors":"L. Fernández Bertolín","doi":"10.1358/dof.2022.47.3.3422310","DOIUrl":"https://doi.org/10.1358/dof.2022.47.3.3422310","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association for Research in Vision and Ophthalmology (ARVO) - 2022 Annual Meeting. Denver/Virtual - May 1-4 and 11-12, 2022 视力和眼科研究协会(ARVO) - 2022年年会。丹佛/Virtual - 2022年5月1-4日和11-12日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.7.3447505
D. Komlos
{"title":"Association for Research in Vision and Ophthalmology (ARVO) - 2022 Annual Meeting. Denver/Virtual - May 1-4 and 11-12, 2022","authors":"D. Komlos","doi":"10.1358/dof.2022.47.7.3447505","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3447505","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Lisbon/Virtual - April 23-26, 2022 第三十二届欧洲临床微生物学和传染病大会。里斯本/虚拟- 2022年4月23-26日
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.8.3455367
E. Torramadé
{"title":"32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Lisbon/Virtual - April 23-26, 2022","authors":"E. Torramadé","doi":"10.1358/dof.2022.47.8.3455367","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3455367","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repotrectinib. ALK/ROS1/TRK inhibitor, Treatment of solid tumors Repotrectinib。ALK/ROS1/TRK抑制剂，治疗实体瘤
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.9.3432774
Z. Li, L. Bo, S. Talukder, Feng-Feng Ping, Z. Chen
{"title":"Repotrectinib. ALK/ROS1/TRK inhibitor, Treatment of solid tumors","authors":"Z. Li, L. Bo, S. Talukder, Feng-Feng Ping, Z. Chen","doi":"10.1358/dof.2022.47.9.3432774","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3432774","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sonelokimab. Interleukin-17A and -F nanobody, Treatment of moderate to severe psoriasis, Treatment of hidradenitis suppurativa Sonelokimab。白细胞介素- 17a和-F纳米体，治疗中重度牛皮癣，治疗化脓性汗腺炎
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.8.3435135
Y. Yao, A. Jørgensen, V. Nielsen, A. Egeberg, J. Thyssen, S. Thomsen
{"title":"Sonelokimab. Interleukin-17A and -F nanobody, Treatment of moderate to severe psoriasis, Treatment of hidradenitis suppurativa","authors":"Y. Yao, A. Jørgensen, V. Nielsen, A. Egeberg, J. Thyssen, S. Thomsen","doi":"10.1358/dof.2022.47.8.3435135","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3435135","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efanesoctocog alfa. Recombinant coagulation factor VIII Fc-von Willebrand factor fusion protein, Treatment of hemophilia A Efanesoctocog阿尔法。重组凝血因子VIII fc -血管性血友病因子融合蛋白，治疗血友病A
IF 0.2 4区 医学
Drugs of The Future Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.10.3455369
L. Villarreal-Martínez, P. L. Zamora-Martinez
{"title":"Efanesoctocog alfa. Recombinant coagulation factor VIII Fc-von Willebrand factor fusion protein, Treatment of hemophilia A","authors":"L. Villarreal-Martínez, P. L. Zamora-Martinez","doi":"10.1358/dof.2022.47.10.3455369","DOIUrl":"https://doi.org/10.1358/dof.2022.47.10.3455369","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信